Jump to content

Recommended Posts

Posted

I understand the idea of how anergy happens but I cannot find a clear explanation for why it happens and why there is no co-stimulation? What regulatory mechanism is preventing the B7 and CD28 receptors from interacting? I ask because at least in the thymus, the T cells are in an isolated and controlled environment and they have a hard time leaving if they have receptors against self. However, the peripheral tissues are like an open area. So what is the regulation that is occurring there?

Posted

"In order to prevent this process, lymphocytes possess an intrinsic quality-control mechanism. This machinery shuts down the lymphocytes' ability to expand, if the trigger for the expansion turns out to be the body's own protein. T-cell anergy can arise when the T-cell does not receive appropriate co-stimulation in the presence of specific antigen recognition. B-cell anergy can be induced by exposure to soluble circulating antigen, and is often marked by a downregulation of surface IgM expression and partial blockade of intracellular signaling pathways."

"In order to prevent this process, lymphocytes possess an intrinsic quality-control mechanism. This machinery shuts down the lymphocytes' ability to expand, if the trigger for the expansion turns out to be the body's own protein. T-cell anergy can arise when the T-cell does not receive appropriate co-stimulation in the presence of specific antigen recognition. B-cell anergy can be induced by exposure to soluble circulating antigen, and is often marked by a downregulation of surface IgM expression and partial blockade of intracellular signaling pathways."

  • 3 months later...
Posted

Here is an article that might help you understand: T cell anergy is a tolerance mechanism in which the lymphocyte is intrinsically functionally inactivated following an antigen encounter, but remains alive for an extended period of time in a hyporesponsive state. Models of T cell anergy affecting both CD4+ and CD8+ cells fall into two broad categories. One, clonal anergy, is principally a growth arrest state, whereas the other, adaptive tolerance or in vivo anergy, represents a more generalized inhibition of proliferation and effector functions.......

  • 9 months later...
Posted

CTLA-4 provides the regulatory mechanism that counteracts B7 and CD28 interaction. CD-4 cells express both CTLA-4 and CD28. B7-CD28 provides the co-stimulatory second signal for T cell activation, but B7-CTLA4 leads to anergy and tolerance in the Th cells.


Mutations in CTLA4 causes autoimmune diseases such as IDDM, Grave's, Hashimoto's, Coeliac's, SLE.

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
×
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.